mark-robinsonMr. Robinson is a Partner at Calusa Capital Partners, a lower-middle market private equity firm based in Naples.

Prior to joining Calusa Capital Partners, Mr. Robinson held various senior operating and investing roles within the financial services industry.  He has over 15 years of experience managing Private Equity investments for an Ultra High Net Worth family, including several cross-border transactions.

In addition, Mr. Robinson provided business valuation and litigation support for two cases brought before the U.S. District Court for the Southern District of Florida.  Bacon v. Stiefel Laboratories was related to GlaxoSmithKline’s roughly $3 billion acquisition of Stiefel Laboratories, while In re: United States Sugar Corporation Litigation, Master File 08-80101-CIV-Middlebrooks was related to the South Florida Water Management District’s proposed $1.75 billion acquisition of land and assets from United States Sugar.

Mr. Robinson holds a B.S. with a double-major in Marketing and Human Resources from Marquette University.  He also holds an MBA with a concentration in Finance from Loyola University Chicago: Quinlan School of Business, where he was inducted into two national honor societies.  In addition to Beta Gamma Sigma, Mr. Robinson was one of 5 members of his graduating class to be nominated into Alpha Sigma Nu.

Currently, Mr. Robinson is a member of the CDW Advisory Board, the Business Valuation Association, and Young Professionals of Naples.